Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charles Dauré"'
Autor:
Laetitia Vanderijst, Felix Hever, Anne Buot, Charles Dauré, Janaïna Benoit, Catherine Hanak, Johannes Veeser, Margot Morgiève, Salvatore Campanella, Charles Kornreich, Luc Mallet, Christophe Leys, Xavier Noël
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives. In parallel, psilocybin-assisted therapy for alcohol use dis
Externí odkaz:
https://doaj.org/article/c8dd5982e9514eaf815cf5b89ab2bcf1
Autor:
Anne Buot, Cecile Pallares, Alina Oganesyan, Charles Dauré, Valérie Bonnelle, Eric Burguière, Joao Flores Alves Dos Santos, Karim N’Diaye, Michael Ljuslin, Pauline Smith, Vincent Verroust, Benjamin Wyplosz, Margot Morgiève, Luc Mallet
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract A renewed interest in the use of psychedelics for treating obsessive compulsive disorder (OCD) has emerged in the last 20 years. But pre-clinical and clinical evidence remain scarce, and little is known about the factor determining the magni
Externí odkaz:
https://doaj.org/article/f20304a97afa4e9c8ff10bcc47b74993
Autor:
Florence Vorspan, Philippe Domenech, David Grabli, Jérôme Yelnik, Marine Delavest, Charles Dauré, Frank Bellivier, Antoine Pelissolo, Hayat Belaid, Christelle Baunez, Carine Karachi, Luc Mallet
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Crack-cocaine dependence is a severe condition with a high mortality rate. This single case study report details the first deep brain stimulation (DBS) trial targeting the sub-thalamic nucleus (STN) for crack-cocaine dependence. The investigation aim
Externí odkaz:
https://doaj.org/article/b28fd32868ba420f92201ac5b0681efa
Autor:
Charles Dauré, Vanessa Bloch, Romain Icick, Maeva Fortias, Elisabeth Avril, Clément Delage, Florence Vorspan
Publikováno v:
Psychiatry Research. 304:114147
Psychiatric disorders, including schizophrenic spectrum disorders, are common in People Who Use Drugs (PWUD). Promoting adherence to medication among PWUD with dual diagnosis is challenging. We present the case of a treatment-disrupted patient suffer